ArticleDiabetologia2010
The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.
A M D Watson et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this papertrialcites it